Sacco Ralph L, Adams Robert, Albers Greg, Alberts Mark J, Benavente Oscar, Furie Karen, Goldstein Larry B, Gorelick Philip, Halperin Jonathan, Harbaugh Robert, Johnston S Claiborne, Katzan Irene, Kelly-Hayes Margaret, Kenton Edgar J, Marks Michael, Schwamm Lee H, Tomsick Thomas
Circulation. 2006 Mar 14;113(10):e409-49.
The aim of this new statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches for the implementation of guidelines and their use in high-risk populations.
本新声明的目的是就缺血性中风或短暂性脑缺血发作幸存者预防缺血性中风提供全面且及时的循证建议。循证建议涵盖危险因素控制、动脉粥样硬化疾病的介入方法、心源性栓塞的抗栓治疗以及非心源性栓塞性中风的抗血小板药物使用。还针对多种其他特定情况预防复发性中风提供了进一步建议,包括动脉夹层;卵圆孔未闭;高同型半胱氨酸血症;高凝状态;镰状细胞病;脑静脉窦血栓形成;女性中风,尤其是关于妊娠和绝经后激素的使用;脑出血后的抗凝使用;以及指南实施及其在高危人群中应用的特殊方法。